AAOS Now reported on the recent platelet rich plasma forum in San Diego.
"The participants of the 2011 PRP Forum also endorsed the development of standards in the manufacture of PRP, noted that PRP may be contraindicated in some conditions, and called for the establishment of a study group to follow up on the other recommendations resulting from the session."
"At the end of the day, an informal survey of participants found most in agreement that PRP would be an option, particularly if conservative treatments have failed and the next step would be surgery."
The group agreed that PRP needs a classification system. Dr. Allan Mishra proposed one that is under consideration.